Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)
Clinical trial NCT04134000 · UNKNOWN
Trial details
- NCT number
- NCT04134000
- Sponsor
- Fundacion Oncosur
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-03
- Primary completion
- 2024-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.